These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10813381)

  • 1. Effects of long-term treatment with nonselective endothelin receptor antagonist, TAK-044, on remodeling of cardiovascular system with sustained volume overload.
    Tojo T; Tsunoda Y; Nakada S; Tomoike H
    J Cardiovasc Pharmacol; 2000 May; 35(5):777-85. PubMed ID: 10813381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonselective endothelin receptor antagonist initiated soon after the onset of myocardial infarction may deteriorate 24-hour survival.
    Takahashi C; Kagaya Y; Namiuchi S; Takeda M; Fukuchi M; Otani H; Ninomiya M; Yamane Y; Kohzuki M; Watanabe J; Shirato K
    J Cardiovasc Pharmacol; 2001 Jul; 38(1):29-38. PubMed ID: 11444500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of endothelin-1 and TAK-044 (ET(A) and ET(B) receptor antagonist) in rats with dilated cardiomyopathy.
    Watanabe K; Ohta Y; Kouda T; Sekiguchi T; Sato S; Nakazawa M; Hasegawa G; Naito M; Fuse K; Ito M; Hirono S; Tanabe N; Hanawa H; Kato K; Kodama M; Aizawa Y
    J Cardiovasc Pharmacol; 2000; 36 Suppl 2():S49-54. PubMed ID: 11206720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal haemodynamic effects of endothelin-1 and the ETA/ETB antagonist TAK-044 in anaesthetized rabbits.
    Evans RG; Bergström G; Cotterill E; Anderson WP
    J Hypertens; 1998 Dec; 16(12 Pt 2):1897-905. PubMed ID: 9886875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic, pulmonary, and renal hemodynamic effects of endothelin ET(A/B)-receptor blockade in patients with maintained left ventricular function.
    Fleisch M; Sütsch G; Yan XW; Wenzel RR; Binggeli C; Bianchetti MG; Meier B; Kiowski W; Lüscher TF
    J Cardiovasc Pharmacol; 2000 Sep; 36(3):302-9. PubMed ID: 10975586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of renal dysfunction in dogs with endotoxemia by a nonselective endothelin receptor antagonist.
    Mitaka C; Hirata Y; Yokoyama K; Nagura T; Tsunoda Y; Amaha K
    Crit Care Med; 1999 Jan; 27(1):146-53. PubMed ID: 9934909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The peptide endothelin receptor antagonist, TAK-044, produces sustained inhibition of endothelin-1 mediated arteriolar vasoconstriction.
    Ferro CJ; Haynes WG; Johnston NR; Lomax CC; Newby DE; Webb DJ
    Br J Clin Pharmacol; 1997 Oct; 44(4):377-83. PubMed ID: 9354313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats.
    Watanabe T; Awane Y; Ikeda S; Fujiwara S; Kubo K; Kikuchi T; Kusumoto K; Wakimasu M; Fujino M
    Br J Pharmacol; 1995 Mar; 114(5):949-54. PubMed ID: 7780649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044.
    Plumpton C; Ferro CJ; Haynes WG; Webb DJ; Davenport AP
    Br J Pharmacol; 1996 Sep; 119(2):311-4. PubMed ID: 8886414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of selective and nonselective endothelin receptor antagonists in mice with heart failure.
    Cavasin MA; Carretero OA; Yang F; Oja-Tebbe N; Peng H; Yang XP
    J Card Fail; 2002 Aug; 8(4):254-61. PubMed ID: 12397574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated reversal of carbon tetrachloride-induced cirrhosis in rats by the endothelin receptor antagonist TAK-044.
    Anselmi K; Subbotin VM; Nemoto E; Gandhi CR
    J Gastroenterol Hepatol; 2002 May; 17(5):589-97. PubMed ID: 12084034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endothelin in a rabbit model of acute myocardial infarction: effects of receptor antagonists.
    Vitola JV; Forman MB; Holsinger JP; Kawana M; Atkinson JB; Quertermous T; Jackson EK; Murray JJ
    J Cardiovasc Pharmacol; 1996 Dec; 28(6):774-83. PubMed ID: 8961075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans.
    Haynes WG; Ferro CJ; O'Kane KP; Somerville D; Lomax CC; Webb DJ
    Circulation; 1996 May; 93(10):1860-70. PubMed ID: 8635265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of nitric oxide in the progression of cardiovascular remodeling induced by carotid arterio-venous shunt in rabbits.
    Miyamoto T; Takeishi Y; Shishido T; Takahashi H; Itoh M; Kubota I; Tomoike H
    Jpn Heart J; 2003 Jan; 44(1):127-37. PubMed ID: 12622444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and biochemical effects of endothelin-A- and -B-receptor antagonist TAK-044 in stroke-prone spontaneously hypertensive rats.
    Naruse M; Tanabe A; Naruse K; Adachi C; Yoshimoto T; Seki T; Takagi S; Imaki T; Watanabe T; Takano K
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S334-6. PubMed ID: 11078413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and renal actions of the endothelin(B) receptor in pigs.
    Cirino M; Martin E; Yano M; Rodger IW
    J Cardiovasc Pharmacol; 1997 Jun; 29(6):704-12. PubMed ID: 9234650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal route of administration of mixed endothelin receptor antagonist (TAK-044) in liver transplantation.
    Tanaka W; Yamanaka N; Onishi M; Ko M; Yamanaka J; Okamoto E
    J Gastroenterol; 2000; 35(2):120-6. PubMed ID: 10680667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of non-selective endothelin blockade, TAK-044, on the ischemic cellular injury of rat heart.
    Geshi E; Nomizo A; Arata Y; Nakatani M; Katagiri T
    Basic Res Cardiol; 1999 Apr; 94(2):94-101. PubMed ID: 10326657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
    Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C
    Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of nonselective endothelin-1 receptor antagonism on cardiac mast cell-mediated ventricular remodeling in rats.
    Murray DB; Gardner JD; Brower GL; Janicki JS
    Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1251-7. PubMed ID: 18178727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.